SRTS
Sensus Healthcare Inc
2.90$
-4.0%
vs. previous close
Closing price · As of: Sep 24, 2026
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | +222.4% | -15.1% | -13.4% | -4.3% | +47.8% | -36.1% | -12.3% | -5.9% | -28.3% | -31.3% | -32.5% | – | |
| – | +148.1% | -15.5% | -4.6% | -5.7% | +65.6% | -33.1% | +10.6% | -5.5% | -27.1% | -21.0% | -36.7% | – | |
| – | +293.6% | -14.9% | -18.6% | -3.4% | +35.6% | -38.7% | -33.3% | -6.5% | -30.0% | -47.8% | -22.4% | – | |
| – | -37.4% | +36.6% | -6.5% | -0.3% | +80.9% | +66.9% | -43.6% | +23.7% | +3.5% | -15.5% | -30.3% | – | |
| – | -37.2% | +66.4% | +0.0% | -0.4% | +53.6% | -8.6% | -10.1% | -3.5% | -8.0% | +15.8% | -12.6% | – | |
| – | -42.0% | +67.6% | -8.8% | +8.8% | +43.7% | +30.1% | -30.8% | +9.0% | -4.4% | +6.0% | -26.2% | – | |
| – | – | -48.2% | -31.3% | -24.6% | +15.5% | -253.3% | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | -46.6% | -29.3% | -19.0% | +10.3% | -225.9% | – | – | – | – | – | – | |
| – | – | -48.2% | -30.0% | -3.5% | -26.7% | -73.2% | -757.3% | – | – | -1,023.6% | – | – | |
| – | – | -46.0% | -29.1% | -24.6% | +27.2% | -266.4% | – | – | – | – | – | – | |
| – | – | -45.5% | -29.5% | -17.3% | +11.4% | -210.9% | – | – | -564.6% | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: September 24, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.